Cargando…
Healthcare resource utilization in the management of hypophosphatasia in three patients displaying a spectrum of manifestations
BACKGROUND: Hypophosphatasia (HPP) is a rare, heterogeneous disease caused by low tissue-nonspecific alkaline phosphatase activity and associated with a range of signs and symptoms, including bone mineralization defects, respiratory problems, seizures, premature tooth loss, and fractures. Data from...
Autores principales: | Daniel, Anjali B., Saraff, Vrinda, Shaw, Nick J., Yates, Robert, Mughal, M. Zulf, Padidela, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097329/ https://www.ncbi.nlm.nih.gov/pubmed/30115096 http://dx.doi.org/10.1186/s13023-018-0869-4 |
Ejemplares similares
-
Characterization of tracheobronchomalacia in infants with hypophosphatasia
por: Padidela, Raja, et al.
Publicado: (2020) -
Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: British paediatric and adolescent bone group recommendations
por: Padidela, Raja, et al.
Publicado: (2020) -
Metabolic bone disease of prematurity—National survey of current neonatal and paediatric endocrine approaches
por: Chinoy, Amish, et al.
Publicado: (2020) -
Dental manifestation and management of hypophosphatasia()
por: Okawa, Rena, et al.
Publicado: (2022) -
Cost-Effectiveness of Vitamin D Supplementation in Pregnant Woman and Young Children in Preventing Rickets: A Modeling Study
por: Floreskul, Vilius, et al.
Publicado: (2020)